Simple and validated HPLC–UV analysis of levetiracetam in deproteinized plasma of patients with epilepsy
- 15 September 2008
- journal article
- research article
- Published by Elsevier BV in Journal of Chromatography B
- Vol. 873 (1), 129-132
- https://doi.org/10.1016/j.jchromb.2008.08.007
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic StrategiesEpilepsia, 2008
- Therapeutic Drug Monitoring of Levetiracetam by High-Performance Liquid Chromatography With Photodiode Array Ultraviolet Detection: Preliminary Observations on Correlation Between Plasma Concentration and Clinical Response in Patients With Refractory EpilepsyTherapeutic Drug Monitoring, 2007
- Drug Monitoring and Toxicology: A Procedure for the Monitoring of Levetiracetam and Zonisamide by HPLC-UVJournal of Analytical Toxicology, 2006
- Determination of levetiracetam in human plasma with minimal sample pretreatmentJournal of Chromatography B, 2005
- High‐performance liquid chromatographic determination of Levetiracetam in human plasma: comparison of different sample clean‐up proceduresBiomedical Chromatography, 2003
- The pharmacokinetic characteristics of levetiracetamMethods and Findings in Experimental and Clinical Pharmacology, 2003
- A Micromethod for the Determination of the New Antiepileptic Drug Levetiracetam (ucb LO59) in Serum or Plasma by High Performance Liquid ChromatographyTherapeutic Drug Monitoring, 1996
- High-performance liquid chromatographic and megabore gas—liquid chromatographic determination of levetiracetam (ucb L059) in human serum after solid-phase extractionJournal of Chromatography B: Biomedical Sciences and Applications, 1994